Medication info

KrevaJet Tablets 10/20 milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202004609 · Approved 2020.06.23

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • increased Apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease caused by hypercholesterolemia.
View approved original text

This medication is used as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and to increase HDL cholesterol. In particular, careful consideration of various risk factors is required when administrating lipid-modifying drugs to patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. The medication should be used along with a diet that restricts saturated fat and cholesterol intake, and it should be administered when dietary measures alone do not provide adequate effect. Prior to administration, secondary causes of dyslipidemia should be identified and treated if necessary, and tests for total cholesterol, LDL, HDL, and triglycerides are mandatory. Follow-up tests should be conducted, and lipid levels should be checked during appropriate times, such as hospitalization for acute coronary events, to inform an appropriate treatment plan. This medication is used to improve lipid levels and lower the risk of cardiovascular disease.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Precautions

This medication can cause a rare side effect known as rhabdomyolysis that may lead to muscle abnormalities; therefore, symptoms such as muscle pain, muscle cramps, and muscle weakness should be reported to a doctor immediately. This medication may affect liver function, so liver function tests should be performed before administration, and tests should be repeated if symptoms of liver dysfunction occur during treatment. Patients with liver disease or those with abnormally elevated liver enzyme levels should not take this medication. This medication should not be administered to patients with severe renal impairment, and caution should be exercised in patients with mildly impaired renal function. This medication may increase blood concentration and risk of side effects if taken with certain drugs; therefore, consult with a doctor or pharmacist if taking other medications. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and women of childbearing age should use appropriate contraception during treatment. Elderly patients are at higher risk for muscle abnormalities, so caution is needed when taking this medication. Safety in children and adolescents has not been sufficiently established, so it is not recommended. While taking this medication, symptoms such as dizziness or headache may occur; caution is required when driving or operating machinery. This medication contains lactose, thus patients with lactose intolerance should not take it. Severe skin reactions may occur while taking this medication, so symptoms such as skin rash, itching, or swelling should be reported to healthcare professionals immediately. In case of overdose, there is no specific antidote, so appropriate treatment and supportive care should be initiated according to the symptoms, and tests for liver function and muscle-related issues should be conducted. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, ALT elevation, edema, myalgia, AST elevation, headache, acute pyelonephritis, dry mouth, liver enzyme elevation, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, increased serum CPK, chest discomfort, dizziness, lethargy, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, chest pain, facial swelling, strange feeling, drug intolerance, colorectal polyps, irritable bowel syndrome, esophagitis, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory decline, forgetfulness, amnesic syndrome, memory impairment, confusion, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, increased serum creatinine, hypertension, elevated blood urea, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue diseases, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, tremors, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival hyperemia, renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tight container to protect it from air and moisture. It is best to store it at room temperature between 1 and 30 degrees.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.